EP4153232
Meðferð með samtengdu TNF-a ónæmisefnasambandi til meðhöndlunar á heilaæxlum
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
24.5.2021EP published:
26.6.2024EP application number:
21726426.6
EP translation filed:
23.9.2024Grant published:
15.10.2024EPO information:
European Patent Register
Max expiry date:
23.5.2041Expiry date:
23.5.2026Next due date:
31.5.2026
Title in English:
TNF-A IMMUNOCONJUGATE THERAPY FOR THE TREATMENT OF BRAIN TUMORSLanguage of the patent:
English
Timeline
Today
24.5.2021EP application
26.6.2024EP Publication
23.9.2024Translation submitted
15.10.2024Registration published
23.5.2026Expires
Owner
Name:
Philogen S.p.A.Address:
La Lizza 7, 53100 Siena, IT
Inventor
Name:
HEMMERLE, TheresaAddress:
8112 Otelfingen, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
20176157Date:
22.5.2020Country:
EP
Classification
Categories:
A61K 39/395, A61K 31/175, A61K 31/495, A61K 38/19, A61P 35/00, C07K 14/525, C07K 16/18, A61K 45/06
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 16.5.2025
Expires: 23.5.2026
Payer: Árnason Faktor ehf.